Latest News

Special cash dividend puts Iveco Group (BIT:IVG) in focus Iveco Group (BIT:IVG) is drawing attention after announcing a special cash dividend of €5.8216 per share, with the ex-dividend date set for April 20, 2026, a development many income-focused investors are watching closely. See our latest analysis for Iveco Group. Despite the special dividend news, Iveco Group’s share price has declined around 26% to €13.99 over the past month. However, its 1 year total shareholder return of 51.21% and 3...

Over the last 7 days, the United States market has risen 3.6%, and over the past year, it has climbed 39%, with earnings expected to grow by 16% annually. Penny stocks may be a throwback term, but they still offer intriguing opportunities for investors seeking growth at lower price points. By focusing on those with strong balance sheets and solid fundamentals, these stocks can present an underappreciated chance for stability and potential upside in today's market conditions.

Recent performance snapshot Zurn Elkay Water Solutions (ZWS) has attracted investor attention following a period in which the stock posted a modest one-day move, weaker performance over the past week, and positive returns over the past month and past three months. See our latest analysis for Zurn Elkay Water Solutions. At a share price of $47.78, Zurn Elkay Water Solutions has recently paired a weaker 7 day share price return with a stronger 1 month share price return, while its 1 year total...

10x Genomics has launched Atera, an in situ spatial biology platform offering whole-transcriptome, single-cell–sensitivity analysis at scale across fresh-frozen and FFPE tissues, with pre-orders open and shipments targeted for the second half of 2026. Early Atera data from leading groups like the June Lab and the German Cancer Research Center suggest the platform can reveal previously hidden tumor–immune interactions that may reshape research and drug discovery approaches. We’ll now examine...

Under Armour (UAA) is back in the spotlight after Unrivaled Sports announced new partnerships with the brand and DICK'S Sporting Goods, focused on youth sports programming nationwide and exclusive apparel roles at marquee events. See our latest analysis for Under Armour. Investors have seen momentum build recently, with a 7 day share price return of 7.65% and a 30 day share price return of 12.99%. At the same time, the 1 year total shareholder return of 15.16% contrasts with a 5 year total...

Morgan Stanley recently elevated Affirm Holdings to its Top Pick list, arguing that concerns around private credit are too pessimistic and pointing to upcoming company updates on gross merchandise volume, margins, and long-term earnings targets at its May Investor Forum as important reference points. An interesting angle is Morgan Stanley’s expectation that Affirm will outline a fiscal 2028 GAAP EPS range that the bank views as conservative, potentially reframing how investors think about...

The United States market has experienced a notable upswing, climbing 3.6% over the last week and an impressive 39% over the past year, with earnings projected to grow by 16% annually. In such a dynamic environment, identifying stocks that are not only poised for growth but also remain under the radar can offer unique opportunities for investors seeking to capitalize on market momentum while discovering potential value.

Skanska stock triggered overview Skanska (OM:SKA B) has come back into focus for investors after recent share price moves, with the stock showing mixed short term returns and a 1 year and 3 year total return profile. See our latest analysis for Skanska. At a share price of SEK258.1, Skanska has recently seen a 6.39% 1 month share price return, while its 1 year total shareholder return of 31.05% and 3 year total shareholder return of 81.66% point to momentum built over a longer horizon. If you...

What recent performance says about East West Bancorp East West Bancorp (EWBC) has drawn attention after a strong month, with the stock showing a 15% return and a gain of about 6% over the past 3 months. This recent performance has prompted some investors to reassess its valuation. See our latest analysis for East West Bancorp. Putting that move in context, the 15.0% 1 month share price return sits alongside a 3.5% year to date share price return and a 60.2% 1 year total shareholder return...

What Recent Performance Tells You About First Majestic Silver First Majestic Silver (TSX:AG) has drawn fresh attention after a strong month, with the share price up about 17%, while the past 3 months show a 5% decline and a 1-year total return above 200%. See our latest analysis for First Majestic Silver. At the current share price of CA$29.44, First Majestic Silver has recently shown strong short term momentum with a 1 month share price return of 17.48%, while the 1 year total shareholder...

Aehr Test Systems overview and recent performance context Aehr Test Systems (AEHR) has drawn attention after a sharp move in its share price, with the stock showing strong returns over the past month, past 3 months and year to date. For context, Aehr Test Systems focuses on designing, manufacturing and marketing advanced test and burn in products used across silicon carbide power devices, sensors, memory and other semiconductor applications. Its market value stands at about US$2.64b, with...

Royal Caribbean Cruises (RCL) has been back on investors’ radar after its stock rallied when Iran temporarily reopened the Strait of Hormuz, easing supply concerns, along with upbeat commentary on the company’s use of artificial intelligence. See our latest analysis for Royal Caribbean Cruises. Beyond the latest geopolitical and AI headlines, Royal Caribbean’s share price has had a mixed few months, with a 7.06% 1 month share price return and a 51.14% 1 year total shareholder return that...

Why the latest earnings matter for China Mobile (SEHK:941) China Mobile (SEHK:941) has just released first quarter 2026 results, with sales of CNY 266,478 million compared with CNY 263,760 million a year earlier, while net income was CNY 29,342 million versus CNY 30,631 million. See our latest analysis for China Mobile. At a share price of HK$83.7, China Mobile’s recent 30 day share price return of 6.22% and 90 day share price return of 5.68% sit alongside a 5 year total shareholder return of...

In April 2026, Marsh & McLennan Companies reported first-quarter 2026 results showing sales of US$7,597 million, net income of US$1,146 million, and lower earnings per share year over year, alongside confirmation that it completed a US$1,074.65 million buyback covering 1.23% of shares since November 2025. While revenue increased compared with the prior year, the combination of declining net income and earnings per share with continued share repurchases highlights a shift in the balance...

GRAIL (GRAL) stock is drawing attention after back to back announcements that extend access to its Galleri multi cancer early detection blood test through Epic’s electronic health record platform and Junction’s digital health infrastructure. See our latest analysis for GRAIL. Investors appear to be weighing these new distribution partnerships against a tougher recent trading history, with the share price at US$51.20, a 7 day share price return of 6.6% and a 90 day share price return showing a...

Cedar Grove Capital Management’s latest Q1 2026 investor letter put RealReal (REAL) in focus, pointing to its role in the fast growing second hand luxury market and recent operational and profitability metrics. See our latest analysis for RealReal. RealReal’s share price has been volatile, with a 36.9% 1 month share price return and a 25.1% decline year to date, while 1 year total shareholder return is 124.5%. If this kind of rebound catches your eye, it could be worth broadening your...

Earlier this month, Ultragenyx Pharmaceutical reported that the US FDA accepted its resubmitted Biologics License Application for UX111, an investigational AAV9 gene therapy for Sanfilippo syndrome Type A, and set a PDUFA action date of 19 September. If UX111 is ultimately approved, it could become the first available treatment for this rare, fatal pediatric neurodegenerative disorder, marking a potentially important expansion of Ultragenyx’s rare-disease gene therapy portfolio. We’ll now...

Index reshuffle puts Casey's in a new spotlight Casey's General Stores (CASY) has moved into a different investor bracket, leaving two Russell small cap composite indices and joining the S&P 500 Equal Weighted Index. This shift can change who owns the stock. This index change arrives as professional investors highlight Casey's for recent fuel margin and in-store sales performance. The development is drawing fresh attention to how the company is currently valued and where its returns are...

AB SKF (OM:SKF B) has drawn investor attention after reporting first quarter 2026 earnings, with sales of SEK 21,873 million and net income of SEK 1,627 million, both lower than a year earlier. See our latest analysis for AB SKF. The latest earnings release and ongoing reorganisation around the separation of the Automotive business appear to be in focus for investors. The share price is at SEK247.6 after a 17.46% 1 month share price return and a 42.59% 1 year total shareholder return,...

Acadia Realty Trust (AKR) has drawn attention after its recent share move, with the stock showing mixed short term performance in recent months and a comparatively stronger pattern over the past year. See our latest analysis for Acadia Realty Trust. At a latest share price of US$21.40, Acadia’s recent 10.37% 1 month share price return contrasts with a small 1 day pullback, while the 1 year total shareholder return of 14.57% and 3 year total shareholder return of 85.06% suggest momentum has...

Restaurant Brands International recently reported quarterly results showing revenue up 7.4% year on year, with both revenue and same-store sales surpassing analyst estimates. This earnings beat highlights how the company’s operational and sales momentum is tracking ahead of external expectations, potentially reinforcing confidence in its existing growth plans. We’ll now examine how this stronger-than-expected same-store sales performance may influence Restaurant Brands International’s...

Gogo Inc. ( NASDAQ:GOGO ), is not the largest company out there, but it received a lot of attention from a substantial...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Vir Biotechnology announced that its global collaboration and licensing agreement with Astellas has closed, bringing in a US$240,000,000 upfront payment, a US$75,000,000 equity investment at US$10.36 per share, and near-term and potential milestone payments tied to the development and commercialization of VIR-5500 for metastatic prostate cancer. At the same time, Vir has begun enrolling an expansion cohort in its Phase 1 trial of VIR-5500 following early safety and anti-tumor signals,...